Business
Why the Alterity (ASX:ATH) share price is skyrocketing 42% today
One of the best performers on the ASX today is the Alterity Therapeutics Ltd (ASX: ATH) share price. Driving the meteoric rise, the biotech company announced positive results for its lead compound, ATH434.
At the time of writing, Alterity shares are swapping hands for 4.25 cents apiece, up 41.67%.
What does Alterity do?
Alterity is an Australian biotech company focused on commercialising research into neurodegenerative disorders. These include Parkinsonian movement disorders, Alzheimer’s disease, Huntington disease and others.
The company’s lead candidate ATH434 is currently in development. It aims to block the aggregation of pathological proteins that cause brain degeneration. Current remedies include medications and lifestyle…
-
General23 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News20 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
General16 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
General16 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire